ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Clinical trial NCT06364774 · RECRUITING

Trial details

NCT number: NCT06364774
Sponsor: Children's Hospital of Philadelphia
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Beta-Thalassemia

Start date: 2025-04-14
Primary completion: 2027-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.